BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Atherotech Diagnostics Lab Release: VAP® Lipid Panel Featured on "The Suzanne Show" With Suzanne Somers


12/27/2012 9:24:52 AM

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Celebrity talk show host Suzanne Somers said it’s important to know more about your cholesterol, including LDL particle size, and that the future of advanced medicine lies in Atherotech Diagnostic Lab’s patented and comprehensive test, the VAP® Lipid Panel. “Large fluffy are good, and small are not good,” the host of The Suzanne Show said of LDL particles in her December 19 season finale episode discussing life-saving blood tests used to predict heart disease and stroke risk. Because the basic lipid panel misses residual cardiovascular risks, health care providers are turning to the preventive power of the VAP (Vertical Auto Profile) Lipid Panel. Somers interviewed Steven Joyal, M.D., chief medical officer at Life Extension®, a Fort Lauderdale, Fla.-based foundation dedicated to the extension of the healthy human lifespan. Joyal told Somers that the VAP Lipid Panel identifies people at risk who would otherwise not be alerted to their cardiovascular disease if they had a conventional cholesterol test. (Watch the episode, “The Future of Advanced Medicine,” at www.atherotech.com/suzanneshow.)

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES